David Keire
Advertisement
David Keire is acting laboratory chief, Branch I, Division of Pharmaceutical Analysis, FDA
Articles by David Keire
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Green Chemistry’s Role in Advancing US Chemical Innovation
2
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
3
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
4
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
5